IRF3 and viral infectious disease: To determine whether IRF3 is more competent in inducing robust antiviral protection due to the presence of S185, we compared the differences in antiviral response to surrogate virus infection [poly(I:C) stimulation] in bat and human cells expressing bat (S185) or human (L185) forms of IRF3, respectively.